RE:Re: HYBRIDAN ValuationPLI is now where it should have been, if they were on the curve on both FDA, and JV partners....Hemosol didn't help....Today, PLI is triping over fundementals, and ahead of the curve.
It is now maintaining business execution and building out on further funementals.
Capital investment, next Q's are strong, and money flow is now trickling in by the millions...lol.
PLI is basically in a news driven category, in which the next meal deal could invariably send the sp soaring...or 0.75 level is a fair bottom value, while $1.30 near term objective milestone...
How can one methodically forecast a growth number in a mid-air fluxuation.
Technically, $1.25 - $1.50 that fast...lol.